| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Mesalamine | 100 | + | |
2 | Cancer Vaccines | 4 | + | |
3 | Neoplasm Proteins | 2 | + | |
4 | Fluorouracil | 2 | + | |
5 | Janus Kinase 2 | 2 | + | |
6 | Tamoxifen | 2 | + | |
7 | Cisplatin | 2 | + | |
8 | Paclitaxel | 2 | + | |
9 | Antibodies, Monoclonal | 2 | + | |
10 | DNA, Neoplasm | 2 | + | |
11 | Receptor, erbB-2 | 2 | + | |
12 | Doxorubicin | 2 | + | |
13 | Receptors, Estrogen | 2 | + | |
14 | Deoxycytidine | 1 | + | |
15 | Taxoids | 1 | + | |
16 | Tumor Suppressor Protein p53 | 1 | + | |
17 | RNA, Small Interfering | 1 | + | |
18 | Antibodies, Monoclonal, Humanized | 1 | + | |
19 | Receptor, Epidermal Growth Factor | 1 | + | |
20 | Androgen Antagonists | 1 | + | |
21 | Prostate-Specific Antigen | 1 | + | |
22 | Antibodies, Neoplasm | 1 | + | |
23 | Organoplatinum Compounds | 1 | + | |
24 | DNA-Binding Proteins | 1 | + | |
25 | Receptors, Progesterone | 1 | + | |
26 | Proto-Oncogene Proteins | 1 | + | |
27 | Quinazolines | 1 | + | |
28 | Carboplatin | 1 | + | |
29 | Camptothecin | 1 | + | |
30 | Cyclophosphamide | 1 | + | |
31 | Janus Kinases | 1 | + | |
32 | Nitriles | 1 | + | |
33 | Proto-Oncogene Proteins c-akt | 1 | + | |
34 | RNA, Messenger | 1 | + | |
35 | Carcinoembryonic Antigen | 1 | + | |
36 | Proto-Oncogene Proteins c-bcl-2 | 1 | + | |
37 | Nuclear Proteins | 1 | + | |
38 | Iodine Radioisotopes | 1 | + | |
39 | Membrane Proteins | 1 | + | |
40 | Phosphatidylinositol 3-Kinases | 1 | + | |
41 | Cyclooxygenase 2 | 1 | + | |
42 | Vinblastine | 1 | + | |
43 | Ki-67 Antigen | 1 | + | |
44 | TOR Serine-Threonine Kinases | 1 | + | |
45 | Cell Cycle Proteins | 1 | + | |
46 | Leucovorin | 1 | + | |
47 | MicroRNAs | 1 | + | |
48 | Estrogen Antagonists | 1 | + | |
49 | Tumor Suppressor Proteins | 1 | + | |
50 | Epirubicin | 1 | + | |
51 | Pyrazoles | 1 | + | |